Clinical Trials on Relapsed/Refractory B-cell Lymphoma, Childhood
Total 4674 results
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
Zhejiang ACEA Pharmaceutical Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Second Affiliated Hospital, School of Medicine,...Carbiogene Therapeutics Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Antengene CorporationActive, not recruiting
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Molecular Templates, Inc.TerminatedRelapsed and/or Refractory Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Nanjing Legend Biotech Co.Ruijin Hospital; Second Affiliated Hospital of Xi'an Jiaotong University; Shanghai... and other collaboratorsActive, not recruitingRefractory or Relapsed Multiple Myeloma
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
First Affiliated Hospital of Zhejiang UniversityCARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
The First Affiliated Hospital of Nanchang UniversityUnknownRelapsed or Refractory Multiple MyelomaChina
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Hebei Yanda Ludaopei HospitalUnknownRelapsed or Refractory Multiple MyelomaChina
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Pineoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Rhabdomyosarcoma | Refractory Medulloblastoma | Refractory Neuroblastoma | Refractory Rhabdomyosarcoma | Central Nervous System Embryonal Tumor With... and other conditionsUnited States, Canada
-
Opna Bio LLCNot yet recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Janssen Research & Development, LLCNot yet recruitingRelapsed or Refractory Multiple Myeloma
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
OriCell Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities LimitedActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
HitGen Inc.TerminatedMultiple Myeloma | Relapsed and Refractory Multiple MyelomaChina